Pharmacokinetics of sparfloxacin and serum bactericidal activity against pneumococci.

Sparfloxacin, a new fluorinated quinolone, exhibits higher in vitro activity against pneumococci than do ciprofloxacin and ofloxacin. Since up to 30% of cases of pneumococcal pneumonia are associated with bacteremia, and since an increasing percentage of pneumococci are resistant against penicillin,...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	Antimicrob Agents Chemother
Principais autores:	Trautmann, M, Ruhnke, M, Borner, K, Wagner, J, Koeppe, P
Format:	Artigo
Sprog:	Inglês
Udgivet:	American Society for Microbiology (ASM) 1996
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163197/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8851610/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.3.776
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!